Is GRP78/BiP a potential salivary biomarker in patients with rheumatoid arthritis?

Purpose: In the last few years, serum and joint synovial fluid have been extensively analyzed for the proteomic research of rheumatoid arthritis (RA) biomarkers. Nonetheless, to date, there have been no studies investigating salivary biomarkers in this condition. Therefore, aim of this study is to investigate the presence of potential biomarkers of RA in human whole saliva.

[1]  S. Bombardieri,et al.  Association of psoriasin (S100A7) with clinical manifestations of systemic sclerosis: is its presence in whole saliva a potential predictor of pulmonary involvement? , 2008, The Journal of rheumatology.

[2]  P. Sham,et al.  Epidermal fatty-acid-binding protein: a new circulating biomarker associated with cardio-metabolic risk factors and carotid atherosclerosis. , 2008, European heart journal.

[3]  L. Wehenkel,et al.  Monomeric calgranulins measured by SELDI-TOF mass spectrometry and calprotectin measured by ELISA as biomarkers in arthritis. , 2008, Clinical chemistry.

[4]  G. Panayi,et al.  BiP, an anti-inflammatory ER protein, is a potential new therapy for the treatment of rheumatoid arthritis. , 2008, Novartis Foundation symposium.

[5]  Y. Takasaki,et al.  Protein biomarker analysis by mass spectrometry in patients with rheumatoid arthritis receiving anti-tumor necrosis factor-alpha antibody therapy. , 2008, Clinical and experimental rheumatology.

[6]  K. Şenel,et al.  The interrelation of glutathione reductase, catalase, glutathione peroxidase, superoxide dismutase, and glucose-6-phosphate in the pathogenesis of rheumatoid arthritis , 2008, Clinical Rheumatology.

[7]  A. Vissink,et al.  Salivary proteomic and genomic biomarkers for primary Sjögren's syndrome. , 2007, Arthritis and rheumatism.

[8]  T. Pincus,et al.  Assessment of quality of rheumatoid arthritis care requires joint count and/or patient questionnaire data not found in a usual medical record: examples from studies of premature mortality, changes in clinical status between 1985 and 2000, and a QUEST-RA global perspective. , 2007, Clinical and experimental rheumatology.

[9]  S. Steer,et al.  The course of established rheumatoid arthritis. , 2007, Best practice & research. Clinical rheumatology.

[10]  Chiara Baldini,et al.  Specific proteins identified in whole saliva from patients with diffuse systemic sclerosis. , 2007, The Journal of rheumatology.

[11]  M. Dougados,et al.  Disease activity measures for rheumatoid arthritis. , 2007, Clinical and experimental rheumatology.

[12]  A. Rozelle,et al.  Efficacy results from pivotal clinical trials with abatacept. , 2007, Clinical and experimental rheumatology.

[13]  A. Aitken,et al.  Detection of high levels of 2 specific isoforms of 14-3-3 proteins in synovial fluid from patients with joint inflammation. , 2007, The Journal of rheumatology.

[14]  C. Fanali,et al.  Proteomic study of salivary peptides and proteins in patients with Sjögren's syndrome before and after pilocarpine treatment. , 2007, Arthritis and rheumatism.

[15]  A. Lomri,et al.  Reactive oxygen species and superoxide dismutases: role in joint diseases. , 2007, Joint, bone, spine : revue du rhumatisme.

[16]  P. Zhu,et al.  Identification of disease-associated proteins by proteomic approach in ankylosing spondylitis. , 2007, Biochemical and biophysical research communications.

[17]  Chiara Baldini,et al.  Proteome analysis of whole saliva: A new tool for rheumatic diseases – the example of Sjögren's syndrome , 2007, Proteomics.

[18]  Peter J Millett,et al.  High abundance synovial fluid proteome: distinct profiles in health and osteoarthritis , 2007, Arthritis research & therapy.

[19]  A. Saraux,et al.  B-cell: a logical target for treatment of rheumatoid arthritis. , 2007, Clinical and experimental rheumatology.

[20]  M. Steultjens,et al.  The relationship of disease duration to foot function, pain and disability in rheumatoid arthritis patients with foot complaints. , 2007, Clinical and experimental rheumatology.

[21]  T. Rabilloud,et al.  Silver staining of proteins in polyacrylamide gels , 2006, Nature Protocols.

[22]  G. Illei,et al.  Identification of parotid salivary biomarkers in Sjogren's syndrome by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry and two-dimensional difference gel electrophoresis. , 2006, Rheumatology.

[23]  Jim Curry,et al.  Proteomic analysis of recurrent joint inflammation in juvenile idiopathic arthritis. , 2006, Journal of proteome research.

[24]  B. Bresnihan.  Synovial biomarkers in the spondylarthropathies , 2006, Current opinion in rheumatology.

[25]  A. Aitken.  14-3-3 proteins: a historic overview. , 2006, Seminars in cancer biology.

[26]  Y. Lee,et al.  Disease-specific Proteins from Rheumatoid Arthritis Patients , 2006, Journal of Korean medical science.

[27]  G. Panayi,et al.  Treatment of murine collagen-induced arthritis by the stress protein BiP via interleukin-4-producing regulatory T cells: a novel function for an ancient protein. , 2006, Arthritis and rheumatism.

[28]  E. S. St. Clair,et al.  New therapeutics in rheumatoid arthritis. , 2006, Rheumatic diseases clinics of North America.

[29]  G. Panayi,et al.  BiP regulates autoimmune inflammation and tissue damage. , 2006, Autoimmunity reviews.

[30]  P. Geurts,et al.  Discovery of new rheumatoid arthritis biomarkers using the surface-enhanced laser desorption/ionization time-of-flight mass spectrometry ProteinChip approach. , 2005, Arthritis and rheumatism.

[31]  D. Foell,et al.  Differential expression and response to anti‐TNFα treatment of infiltrating versus resident tissue macrophage subsets in autoimmune arthritis , 2005, The Journal of pathology.

[32]  W. Bigbee,et al.  Serum protein profile in systemic-onset juvenile idiopathic arthritis differentiates response versus nonresponse to therapy , 2005, Arthritis research & therapy.

[33]  Tomohiro Kato,et al.  Autoantibodies to Peroxiredoxin I and IV in Patients with Systemic Autoimmune Diseases , 2005, Microbiology and immunology.

[34]  I. Haas,et al.  BiP (GRP78), an essential hsp70 resident protein in the endoplasmic reticulum , 1994, Experientia.

[35]  K. Clauser,et al.  Use of mass spectrometry to identify protein biomarkers of disease severity in the synovial fluid and serum of patients with rheumatoid arthritis. , 2004, Arthritis and rheumatism.

[36]  C. Hitchon,et al.  Oxidation in rheumatoid arthritis , 2004, Arthritis research & therapy.

[37]  B. Bresnihan,et al.  Apolipoprotein A-I infiltration in rheumatoid arthritis synovial tissue: a control mechanism of cytokine production? , 2004, Arthritis research & therapy.

[38]  S. Rantapää-Dahlqvist,et al.  Antibody response to the human stress protein BiP in rheumatoid arthritis. , 2004, Rheumatology.

[39]  G. Panayi,et al.  BiP: a new biologic immunomodulator for the treatment of rheumatoid arthritis. , 2004, Autoimmunity reviews.

[40]  H. Fukuda,et al.  Proteomic surveillance of autoimmunity in osteoarthritis: identification of triosephosphate isomerase as an autoantigen in patients with osteoarthritis. , 2004, Arthritis and rheumatism.

[41]  Pier Giorgio Righetti,et al.  Blue silver: A very sensitive colloidal Coomassie G‐250 staining for proteome analysis , 2004, Electrophoresis.

[42]  G. Panayi,et al.  Inhibition of antigen-presenting cell function and stimulation of human peripheral blood mononuclear cells to express an antiinflammatory cytokine profile by the stress protein BiP: relevance to the treatment of inflammatory arthritis. , 2004, Arthritis and rheumatism.

[43]  W. Ens,et al.  The synovial proteome: analysis of fibroblast-like synoviocytes , 2004, Arthritis research & therapy.

[44]  G. Panayi,et al.  BiP, a putative autoantigen in rheumatoid arthritis, stimulates IL-10-producing CD8-positive T cells from normal individuals. , 2003, Rheumatology.

[45]  L. Flohé,et al.  Peroxiredoxins in antioxidant defense and redox regulation. , 2003, BioFactors.

[46]  Z. A. Wood,et al.  Structure, mechanism and regulation of peroxiredoxins. , 2003, Trends in biochemical sciences.

[47]  T. Uchida,et al.  Application of a novel protein biochip technology for detection and identification of rheumatoid arthritis biomarkers in synovial fluid. , 2002, Journal of proteome research.

[48]  G. Panayi,et al.  PATHOGENESIS OF RHEUMATOID ARTHRITIS , 2001 .

[49]  N. Hyka,et al.  Articles on similar topics can be found in the following Blood collections , 2013 .

[50]  F. Schumann,et al.  The stress protein BiP is overexpressed and is a major B and T cell target in rheumatoid arthritis. , 2001, Arthritis and rheumatism.

[51]  Z. Stelmasiak,et al.  Biochemical markers of damage of the central nervous system in multiple sclerosis. , 2001, Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina.

[52]  T. Ochi.  The human endoplasmic reticulum molecular chaperone bip is an autoantigen for rheumatoid arthritis and prevents the induction of experimental arthritis , 2000 .

[53]  M. Gething.  Role and regulation of the ER chaperone BiP. , 1999, Seminars in cell & developmental biology.

[54]  J. Saurat,et al.  Calcium-binding protein S100A7 and epidermal-type fatty acid-binding protein are associated in the cytosol of human keratinocytes. , 1999, The Biochemical journal.

[55]  C. Specker,et al.  Rheumatoid arthritis: autoreactive T cells recognising a novel 68k autoantigen , 1997, Annals of the rheumatic diseases.

[56]  A. Aitken.  14-3-3 and its possible role in co-ordinating multiple signalling pathways. , 1996, Trends in cell biology.

[57]  C. Specker,et al.  Novel 68 kDa autoantigen detected by rheumatoid arthritis specific antibodies. , 1995, Annals of the rheumatic diseases.

[58]  D F Hochstrasser,et al.  Development of polyacrylamide gels that improve the separation of proteins and their detection by silver staining. , 1988, Analytical biochemistry.

[59]  M. Liang,et al.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. , 1988, Arthritis and rheumatism.